Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

[Thrombosis of lower-limb deep veins: a present-day view on conservative treatment].

Soroka VV, Fomin KN, Nokhrin SP, Belousov EI.

Angiol Sosud Khir. 2017;23(3):185-191. Russian.

PMID:
28902832
2.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

3.

Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor.

Hennen S, Kodra JT, Soroka V, Krogh BO, Wu X, Kaastrup P, Ørskov C, Rønn SG, Schluckebier G, Barbateskovic S, Gandhi PS, Reedtz-Runge S.

Sci Rep. 2016 May 19;6:26236. doi: 10.1038/srep26236.

4.

[Combined treatment of complicated forms of angiodysplasias in conditions of a multimodality hospital].

Soroka VV, Borovsky IE, Khomchuk IA, Ovcharenko DV, Magamedov ID.

Angiol Sosud Khir. 2015;21(3):124-8. Russian.

PMID:
26355932
5.

Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 Variants per Genome Can Bind IgM via Its Fc Fragment Fcμ.

Jeppesen A, Ditlev SB, Soroka V, Stevenson L, Turner L, Dzikowski R, Hviid L, Barfod L.

Infect Immun. 2015 Oct;83(10):3972-81. doi: 10.1128/IAI.00337-15. Epub 2015 Jul 27.

6.

[Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].

Demyanenko AV, Kapustin SI, Soroka VV, Chechulov PV.

Angiol Sosud Khir. 2015;21(2):21-5. Russian.

PMID:
26035561
7.

Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injury.

Samama CM, Lecoules N, Kierzek G, Claessens YE, Riou B, Rosencher N, Mismetti P, Sautet A, Barrellier MT, Apartsin K, Jonas M, Caeiro JR, van der Veen AH, Roy PM; FONDACAST Study Group.

J Thromb Haemost. 2013 Oct;11(10):1833-43. doi: 10.1111/jth.12395.

8.

Oral apixaban for the treatment of acute venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators.

N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1.

9.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

10.

[Primary aorto-intestinal fistulas (review of the literature and description of clinical case reports)].

Andreĭchuk KA, Soroka VV, Postnov AA, Kagachev PN, Kechaeva EI, Andreĭchuk NN.

Angiol Sosud Khir. 2012;18(3):153-8. Review. Russian.

PMID:
23339258
11.

Apixaban for extended treatment of venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; AMPLIFY-EXT Investigators.

N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8.

12.

The metastasis-promoting S100A4 protein confers neuroprotection in brain injury.

Dmytriyeva O, Pankratova S, Owczarek S, Sonn K, Soroka V, Ridley CM, Marsolais A, Lopez-Hoyos M, Ambartsumian N, Lukanidin E, Bock E, Berezin V, Kiryushko D.

Nat Commun. 2012;3:1197. doi: 10.1038/ncomms2202.

PMID:
23149742
13.

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.

Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators.

Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28.

PMID:
22130488
14.

[Hybrid operating room: a new horizon in cardiovascular surgery].

Soroka VV, Andreĭchuk KA, Kechaeva EI, Postnov AA, Kagachev PN.

Angiol Sosud Khir. 2011;17(3):93-101. Russian.

PMID:
22027527
15.

Neuroplastin-65 and a mimetic peptide derived from its homophilic binding site modulate neuritogenesis and neuronal plasticity.

Owczarek S, Soroka V, Kiryushko D, Larsen MH, Yuan Q, Sandi C, Berezin V, Bock E.

J Neurochem. 2011 Jun;117(6):984-94. doi: 10.1111/j.1471-4159.2011.07269.x. Epub 2011 May 13.

16.

[The world's fist successful closure of the wound of the ascending aorta. Russian priority].

Soroka VV, Nikonova NV.

Angiol Sosud Khir. 2011;17(4):127-8. Russian.

PMID:
22616241
17.

[Transluminal balloon angioplasty as a method of choice in treatment of critical ischemia of lower extremities].

Kaputin MIu, Ovcharenko DV, Boĭtsova OV, Sidorov VN, Soroka VV, Dudanov IP.

Vestn Khir Im I I Grek. 2010;169(4):49-54. Russian.

PMID:
20973186
18.

Fondaparinux for the treatment of superficial-vein thrombosis in the legs.

Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A; CALISTO Study Group.

N Engl J Med. 2010 Sep 23;363(13):1222-32. doi: 10.1056/NEJMoa0912072.

19.

Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.

Pankratova S, Kiryushko D, Sonn K, Soroka V, Køhler LB, Rathje M, Gu B, Gotfryd K, Clausen O, Zharkovsky A, Bock E, Berezin V.

Brain. 2010 Aug;133(Pt 8):2281-94. doi: 10.1093/brain/awq101. Epub 2010 Apr 30.

PMID:
20435631
20.

A peptide antagonist of the ErbB1 receptor inhibits receptor activation, tumor cell growth and migration in vitro and xenograft tumor growth in vivo.

Xu R, Povlsen GK, Soroka V, Bock E, Berezin V.

Cell Oncol. 2010 Jan 1;32(4):259-74. doi: 10.3233/CLO-2010-0515.

Supplemental Content

Loading ...
Support Center